INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 67
RESEARCH DOSSIER / NOT AN ENDORSEMENT

EverSlim

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Doctor-prescribed weight loss, delivered' - honest flat pricing, no insurance/membership, 'a clinic in your pocket'; 11,000+ patients, 4.9/5 by 2,400+ patients; explicit AI-content disclosure (testimonial imagery may be AI-generated/actors); LegitScript certified.

Audienceread

read: convenience-first US adults 25-55 wanting low-friction async care; price-transparency-sensitive

Pricing & termsverified

Compounded semaglutide from $113/mo; compounded tirzepatide from $136/mo; includes provider visit, prescription, delivery; no membership

Clinical relationshipsverified

CareGLP Affiliated P.C.s and DrTelx (provider groups); async care in 44 states, synchronous required in DC/KS/LA/MS/NM/RI/WV

Pharmacy & fulfillmentverified

EPIQ Scripts, Foothills Pharmacy, Emerald Compounding Pharmacy (state-licensed; NABP-accredited claimed)

Advertising snapshotsnapshot

Meta US active advertiser page: ~10 results. Google US last-30-days domain search: 23 ads. Sample last shown Oct 10, 2026.

Founding yearnot_found

Founding year not established. Terms effective 30 Jun 2026 date a document, not business founding.

Foundersnot_found

Founder identities not established; support-email first names are not used.

Location & entity contextpartial

EverSlim (MSO) operating on technology platform provided by Rimo, Inc.; governing law Florida, venue Miami-Dade County; no physical address published

Search visibility samplesnapshot

'As seen in' Forbes/Yahoo/WebMD/New York Post logo claims (unverified); LegitScript certification (verifiable per site); minimal third-party review presence found.

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.